{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:31:58Z","timestamp":1793971918753,"version":"4.8.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185970","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T17:39:47Z","timestamp":1507570787000},"page":"e0185970","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Behavioral testing of minipigs transgenic for the Huntington gene\u2014A three-year observational study"],"prefix":"10.1371","volume":"12","author":[{"given":"Verena","family":"Schuldenzucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Freisfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Matheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schramke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Motlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Radespiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5904-9517","authenticated-orcid":true,"given":"Ralf","family":"Reilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"issue":"9557","key":"ref1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"FO Walker","year":"2007","journal-title":"The Lancet"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"M MacDonald","year":"1993","journal-title":"Cell"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.26014","article-title":"Current therapeutic options for Huntington\u2019s disease: Good clinical practice versus evidence-based approaches?","volume":"29","author":"A Killoran","year":"2014","journal-title":"Mov Disord"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"SJ Tabrizi","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington\u2019s disease","volume":"27","author":"CS Venuto","year":"2012","journal-title":"Mov Disord"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/mds.26008","article-title":"Mind the gap: Models in multiple species needed for therapeutic development in Huntington\u2019s disease: HOWLAND AND MUNOZ-SANJUAN","volume":"29","author":"DS Howland","year":"2014","journal-title":"Mov Disord"},{"key":"ref7","article-title":"Mouse Models for Validating Preclinical Candidates for Huntington\u2019s Disease [Internet]","author":"XW Yang","year":"2011"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JHD-130050","article-title":"Genetic Animal Models of Huntington\u2019s Disease","volume":"2","author":"AJ Morton","year":"2013","journal-title":"J Huntingt Dis"},{"issue":"1","key":"ref9","first-page":"47","article-title":"A Transgenic Minipig Model of Huntington&amp;apos;s Disease","author":"B Monika","year":"2013","journal-title":"J Huntington\u2019s Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jneumeth.2015.11.013","article-title":"Behavioral phenotyping of minipigs transgenic for the Huntington gene","volume":"265","author":"S Schramke","year":"2016","journal-title":"J Neurosci Methods"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: Reliability and consistency","volume":"11","year":"1996","journal-title":"Mov Disord"},{"issue":"S 02","key":"ref12","doi-asserted-by":"crossref","first-page":"P474","DOI":"10.1055\/s-0029-1238568","article-title":"A teaching film, video library and online certification for the Unified Huntington\u2019s Disease Rating Scale Total Motor Score","volume":"36","author":"R Reilmann","year":"2009","journal-title":"Aktuelle Neurol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.baga.2012.09.004","article-title":"Huntington\u2019s disease: Towards disease modification\u2014Gaps and bridges, facts and opinions","volume":"2","author":"R Reilmann","year":"2012","journal-title":"Basal Ganglia"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"SJ Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"SJ Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/mds.26174","article-title":"A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington\u2019s disease","volume":"30","author":"R Reilmann","year":"2015","journal-title":"Mov Disord"},{"issue":"16","key":"ref17","article-title":"Efficacy, Safety, and Tolerability of Pridopidine in Huntington Disease (HD): Results from the Phase II, Double-blind, Placebo-controlled, Dose-Ranging Study, Pride-HD (P2.005)","volume":"88","author":"K Kieburtz","year":"2017","journal-title":"Neurology"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/mds.23243","article-title":"Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington\u2019s disease","volume":"25","author":"R Reilmann","year":"2010","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/S355","article-title":"A review of cognition in Huntington\u00b4s disease","author":"E Dumas","year":"2013","journal-title":"Front Biosci"},{"issue":"APR","key":"ref20","article-title":"Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study","volume":"6","author":"JS Paulsen","year":"2014","journal-title":"Front Aging Neurosci [Internet]"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","article-title":"Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington\u2019s disease","volume":"83","author":"JC Stout","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington\u2019s Disease Mutation","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"issue":"4","key":"ref23","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"D Craufurd","year":"2001","journal-title":"Cogn Behav Neurol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JHD-140127","article-title":"Aggression in Huntington\u2019s Disease: A Systematic Review of Rates of Aggression and Treatment Methods","volume":"3","author":"CA Fisher","year":"2014","journal-title":"J Huntingt Dis"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0092-8674(00)80354-2","article-title":"Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1","volume":"90","author":"N Lijam","year":"1997","journal-title":"Cell"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0304-3762(83)90008-1","article-title":"Tube dominance in piglets. Structure and stability of dominance order","volume":"9","author":"S Sz\u00e9kely","year":"1983","journal-title":"Appl Anim Ethol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.anbehav.2009.12.009","article-title":"Choosing an appropriate index to construct dominance hierarchies in animal societies: a comparison of three indices","volume":"79","author":"A Bang","year":"2010","journal-title":"Anim Behav"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/cne.23575","article-title":"Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies","volume":"522","author":"D Dolezalova","year":"2014","journal-title":"J Comp Neurol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington\u2019s disease: What\u2019s in the pipeline?","volume":"29","author":"EJ Wild","year":"2014","journal-title":"Mov Disord"},{"key":"ref30","first-page":"39","article-title":"Stem Cell Renewal and Cell-Cell Communication [Internet]","author":"I Valekova","year":"2015"},{"key":"ref31","article-title":"Design of the Legato-hd study: A multinational, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of laquinimod (0.5, 1.0 and 1.5 mg\/day) as treatment in patients with Huntington\u2019s disease: 1391","volume":"30","author":"R Reilmann","year":"2015","journal-title":"Mov Disord [Internet]"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington\u2019s Disease: Can Mice Lead the Way to Treatment?","volume":"69","author":"ZR Crook","year":"2011","journal-title":"Neuron"},{"key":"ref33","first-page":"419","article-title":"International Review of Neurobiology [Internet]","author":"J Kim","year":"2011"},{"key":"ref34","article-title":"Neurobiology of Huntington\u2019s Disease: Applications to Drug Discovery [Internet]","author":"X William Yang","year":"2011"},{"issue":"S2","key":"ref35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14735\/amcsnn20152S55","article-title":"The Libechov Minipig as a Large Animal Model for Preclinical Research in Huntington\u2019s disease\u2014Thoughts and Perspectives","volume":"78\/111","author":"S Schramke","year":"2015","journal-title":"\u010ces Slov Neurol Neurochir"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneumeth.2015.11.017","article-title":"Neuroimaging of a minipig model of Huntington\u2019s disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments","volume":"265","author":"R Schubert","year":"2016","journal-title":"J Neurosci Methods"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7150\/ijbs.3.179","article-title":"Advances in swine biomedical model genomics","volume":"3","author":"JK Lunney","year":"2007","journal-title":"Int J Biol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T23:25:12Z","timestamp":1603063512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185970"}},"subtitle":[],"editor":[{"given":"Xiao-Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185970","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]}}}